Unforeseen Reactions In February 2025, the paper, Euglycemic Ketoacidosis Following Coadministration of an SGLT2 Inhibitor and Tirzepatide , appeared in JCEM Case Reports , describing a patient who was admitted to the intensive care unit after being placed on both medications
If you're taking a GLP-1 medication, you may have found that you're eating less and feeling full more quickly
MODULE 3 What NOT to Eat on GLP-1 Instead of learning through trial and error, we'll provide clear guidelines on which foods, drinks, spices, and products to watch out for
Adjustment of Insulin Therapy in Patients with Type 1 Diabetes (T1DM) It has been shown that relevant doses of transiently administered GCs (in the referenced study 60 mg prednisone/day) lead to an increase in insulin requirements of 70% on average with considerable inter-individual variation to normalize blood glucose levels in patients with previously known well controlled T1DM
3A and Extended Data file)